High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$162M
$162,268,437
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.8%
2026-03-11
$163,428
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.8%
|
2026-03-11 | $163,428 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-11 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $191,566 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $128,032 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-11 | $441,512 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.8%
2026-03-11
$652,390
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.8%
|
2026-03-11 | $652,390 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.8%
2026-03-11
$595,040
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.8%
|
2026-03-11 | $595,040 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.6%
2026-03-11
$590,121
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.6%
|
2026-03-11 | $590,121 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.5%
2026-03-11
$453,658
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.5%
|
2026-03-11 | $453,658 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.9%
2026-03-11
$509,664
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.9%
|
2026-03-11 | $509,664 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -39.2%
2026-03-11
$638,631
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -39.2%
|
2026-03-11 | $638,631 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.1%
2026-03-11
$130,328
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.1%
|
2026-03-11 | $130,328 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -73.0%
2026-03-11
$631,276
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -73.0%
|
2026-03-11 | $631,276 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-10 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.4%
2026-03-10
$216,676
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.4%
|
2026-03-10 | $216,676 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.3%
2026-03-10
$237,877
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.3%
|
2026-03-10 | $237,877 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.9%
2026-03-10
$729,322
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.9%
|
2026-03-10 | $729,322 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $303,470 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $348,036 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.2%
2026-03-10
$304,013
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.2%
|
2026-03-10 | $304,013 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -28.5%
2026-03-10
$448,290
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -28.5%
|
2026-03-10 | $448,290 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -45.3%
2026-03-10
$510,169
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -45.3%
|
2026-03-10 | $510,169 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -42.5%
2026-03-10
$262,180
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -42.5%
|
2026-03-10 | $262,180 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.5%
2026-03-10
$218,855
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.5%
|
2026-03-10 | $218,855 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.0%
|
2026-03-10 | $65,772 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $246,019 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.3%
2026-03-10
$706,321
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.3%
|
2026-03-10 | $706,321 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $21,329 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $21,262 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $63,658 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-10 | $424,024 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.2%
2026-03-09
$242,203
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.2%
|
2026-03-09 | $242,203 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-09 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $100,010 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $124,317 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $358,075 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.6%
2026-03-09
$458,514
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.6%
|
2026-03-09 | $458,514 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $309,269 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $347,226 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $290,919 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.8%
2026-03-09
$349,720
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.8%
|
2026-03-09 | $349,720 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.6%
2026-03-09
$303,785
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.6%
|
2026-03-09 | $303,785 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $165,187 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $187,286 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.7%
2026-03-09
$270,396
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.7%
|
2026-03-09 | $270,396 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.9%
2026-03-09
$174,878
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.9%
|
2026-03-09 | $174,878 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $86,381 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-09 | $62,982 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.9%
2026-03-09
$126,384
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.9%
|
2026-03-09 | $126,384 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -54.5%
2026-03-09
$562,797
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -54.5%
|
2026-03-09 | $562,797 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -76.3%
2026-03-09
$358,561
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -76.3%
|
2026-03-09 | $358,561 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.1%
|
2026-03-09 | $42,386 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -21.6%
2026-03-06
$279,144
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.6%
|
2026-03-06 | $279,144 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.0%
2026-03-06
$579,723
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.0%
|
2026-03-06 | $579,723 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -35.9%
2026-03-06
$1,047,699Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -35.9%
|
2026-03-06 | $1,047,699Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.6%
2026-03-06
$419,202
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.6%
|
2026-03-06 | $419,202 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.8%
2026-03-06
$531,449
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.8%
|
2026-03-06 | $531,449 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -11.0%
2026-03-06
$474,596
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -11.0%
|
2026-03-06 | $474,596 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $114,049 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-06 | $134,038 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-06 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -44.3%
2026-03-06
$450,681
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -44.3%
|
2026-03-06 | $450,681 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.3%
2026-03-06
$115,582
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.3%
|
2026-03-06 | $115,582 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.3%
|
2026-03-06 | $96,547 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.8%
2026-03-06
$217,659
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.8%
|
2026-03-06 | $217,659 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.2%
|
2026-03-06 | $77,483 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.5%
2026-03-05
$624,422
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.5%
|
2026-03-05 | $624,422 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $245,844 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $231,148 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-05 | $133,889 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-05 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -81.9%
2026-03-05
$286,445
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -81.9%
|
2026-03-05 | $286,445 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.6%
2026-03-05
$583,938
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.6%
|
2026-03-05 | $583,938 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -49.2%
2026-03-05
$1,273,121Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -49.2%
|
2026-03-05 | $1,273,121Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.4%
2026-03-05
$836,435
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.4%
|
2026-03-05 | $836,435 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.4%
2026-03-05
$387,990
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.4%
|
2026-03-05 | $387,990 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -73.8%
2026-03-04
$237,976
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -73.8%
|
2026-03-04 | $237,976 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.6%
|
2026-03-04 | $91,279 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.8%
2026-03-04
$119,663
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.8%
|
2026-03-04 | $119,663 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.3%
2026-03-04
$238,296
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.3%
|
2026-03-04 | $238,296 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -50.4%
2026-03-04
$886,858
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -50.4%
|
2026-03-04 | $886,858 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -39.0%
2026-03-04
$1,121,367Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -39.0%
|
2026-03-04 | $1,121,367Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.2%
2026-03-04
$1,186,882Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.2%
|
2026-03-04 | $1,186,882Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.0%
2026-03-04
$451,475
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.0%
|
2026-03-04 | $451,475 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-04 | $194,083 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -49.7%
2026-03-04
$1,387,285Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -49.7%
|
2026-03-04 | $1,387,285Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2026-03-04 | $19,882 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.9%
2026-03-04
$106,369
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.9%
|
2026-03-04 | $106,369 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.5%
2026-03-03
$247,975
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.5%
|
2026-03-03 | $247,975 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -76.4%
2026-03-03
$213,485
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -76.4%
|
2026-03-03 | $213,485 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -19.3%
|
2026-03-03 | $66,813 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -57.1%
2026-03-03
$458,594
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -57.1%
|
2026-03-03 | $458,594 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.4%
2026-03-03
$367,914
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.4%
|
2026-03-03 | $367,914 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $105,637 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -13.0%
2026-03-03
$190,232
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -13.0%
|
2026-03-03 | $190,232 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.7%
2026-03-03
$528,846
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.7%
|
2026-03-03 | $528,846 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2026-03-03
$684,067
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2026-03-03 | $684,067 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.6%
2026-03-03
$535,362
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.6%
|
2026-03-03 | $535,362 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $202,161 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $275,209 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $336,431 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $225,132 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $167,462 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-03 | $139,146 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-03 | $1,387,285Large | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.5%
2026-03-02
$535,610
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.5%
|
2026-03-02 | $535,610 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.2%
2026-03-02
$396,281
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.2%
|
2026-03-02 | $396,281 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -25.2%
2026-03-02
$450,843
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -25.2%
|
2026-03-02 | $450,843 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.1%
2026-03-02
$309,676
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.1%
|
2026-03-02 | $309,676 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.1%
2026-03-02
$165,550
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.1%
|
2026-03-02 | $165,550 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.3%
2026-03-02
$124,292
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.3%
|
2026-03-02 | $124,292 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.4%
2026-03-02
$218,850
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.4%
|
2026-03-02 | $218,850 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $162,208 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $81,163 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2026-03-02 | $1,387,285Large | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $217,625 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $158,936 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.1%
2026-03-02
$548,117
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.1%
|
2026-03-02 | $548,117 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.7%
2026-03-02
$156,642
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.7%
|
2026-03-02 | $156,642 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2026-03-02 | $369,627 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -53.5%
2026-03-02
$198,289
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -53.5%
|
2026-03-02 | $198,289 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.5%
|
2026-03-02 | $83,847 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2026-03-02 | $21,011 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.7%
2026-03-02
$697,452
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.7%
|
2026-03-02 | $697,452 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-12-19
$761,418
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-12-19 | $761,418 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-19 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2025-12-19
$252,725
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2025-12-19 | $252,725 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-19 | $240,520 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-18 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-12-18
$766,295
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-12-18 | $766,295 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.5%
2025-12-18
$254,708
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.5%
|
2025-12-18 | $254,708 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-12-18
$1,014,486Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-12-18 | $1,014,486Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-18 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-17
$750,780
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-17 | $750,780 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-17 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.1%
2025-12-17
$1,253,367Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.1%
|
2025-12-17 | $1,253,367Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-17 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-12-16
$1,231,234Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-12-16 | $1,231,234Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.4%
2025-12-16
$494,000
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.4%
|
2025-12-16 | $494,000 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-16 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-16 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-12-16
$248,585
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-12-16 | $248,585 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.4%
2025-12-15
$1,732,984Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.4%
|
2025-12-15 | $1,732,984Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-12-15
$245,885
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-12-15 | $245,885 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-15 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.7%
2025-12-12
$1,423,834Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.7%
|
2025-12-12 | $1,423,834Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-12 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-12-12
$538,949
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-12-12 | $538,949 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-12 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-11
$724,682
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-11 | $724,682 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -80.1%
2025-12-11
$254,213
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -80.1%
|
2025-12-11 | $254,213 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -75.1%
2025-12-11
$956,984
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -75.1%
|
2025-12-11 | $956,984 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-11 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-11 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -32.0%
2025-12-08
$482,920
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -32.0%
|
2025-12-08 | $482,920 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-08 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-12-08
$244,485
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-12-08 | $244,485 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.8%
2025-12-08
$194,312
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.8%
|
2025-12-08 | $194,312 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -51.5%
2025-12-08
$529,128
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -51.5%
|
2025-12-08 | $529,128 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.4%
2025-12-08
$486,091
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.4%
|
2025-12-08 | $486,091 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-08 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-05 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-05 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -72.6%
2025-12-05
$1,448,810Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -72.6%
|
2025-12-05 | $1,448,810Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-12-05
$484,310
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-12-05 | $484,310 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.2%
2025-12-04
$1,247,151Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.2%
|
2025-12-04 | $1,247,151Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-04 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-04 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -34.0%
2025-12-04
$672,893
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -34.0%
|
2025-12-04 | $672,893 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.7%
2025-12-03
$781,063
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.7%
|
2025-12-03 | $781,063 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-12-03
$711,152
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-12-03 | $711,152 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -32.7%
2025-12-03
$408,873
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -32.7%
|
2025-12-03 | $408,873 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-03 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -16.0%
2025-12-02
$240,070
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -16.0%
|
2025-12-02 | $240,070 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-02 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-02 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.0%
2025-12-02
$835,989
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.0%
|
2025-12-02 | $835,989 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-12-02
$478,640
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-12-02 | $478,640 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.2%
2025-12-02
$370,443
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.2%
|
2025-12-02 | $370,443 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-12-01 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.5%
2025-12-01
$763,638
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.5%
|
2025-12-01 | $763,638 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -54.7%
2025-12-01
$670,368
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -54.7%
|
2025-12-01 | $670,368 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -45.2%
2025-12-01
$251,358
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -45.2%
|
2025-12-01 | $251,358 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-12-01
$242,340
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-12-01 | $242,340 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-11-28 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-28 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -19.4%
2025-11-28
$388,570
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -19.4%
|
2025-11-28 | $388,570 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.3%
2025-11-28
$784,058
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.3%
|
2025-11-28 | $784,058 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.4%
2025-11-28
$532,797
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.4%
|
2025-11-28 | $532,797 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-11-28
$245,125
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-11-28 | $245,125 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -51.7%
2025-11-26
$1,033,816Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -51.7%
|
2025-11-26 | $1,033,816Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -68.4%
2025-11-26
$662,838
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -68.4%
|
2025-11-26 | $662,838 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-11-26
$243,550
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-11-26 | $243,550 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-26 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -37.2%
2025-11-25
$727,585
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -37.2%
|
2025-11-25 | $727,585 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.8%
2025-11-25
$144,369
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.8%
|
2025-11-25 | $144,369 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -83.4%
2025-11-25
$1,029,351Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -83.4%
|
2025-11-25 | $1,029,351Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-25 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-11-24
$1,174,319Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-11-24 | $1,174,319Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-11-24
$708,795
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-11-24 | $708,795 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-24 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-21
$709,972
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-21 | $709,972 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.8%
|
2025-11-21 | $23,804 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-21 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.2%
2025-11-21
$1,164,783Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.2%
|
2025-11-21 | $1,164,783Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.5%
2025-11-20
$400,208
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.5%
|
2025-11-20 | $400,208 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-11-20
$476,803
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-11-20 | $476,803 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-20 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.2%
2025-11-20
$1,036,513Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.2%
|
2025-11-20 | $1,036,513Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-19 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-11-19
$949,900
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-11-19 | $949,900 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-11-19
$948,436
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-11-19 | $948,436 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-11-18
$712,642
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-11-18 | $712,642 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-18 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-18
$705,800
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-18 | $705,800 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.0%
2025-11-18
$472,595
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.0%
|
2025-11-18 | $472,595 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-11-17
$699,390
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-11-17 | $699,390 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-17 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.1%
2025-11-17
$1,170,802Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.1%
|
2025-11-17 | $1,170,802Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-14
$230,170
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-14 | $230,170 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -81.4%
2025-11-14
$265,648
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -81.4%
|
2025-11-14 | $265,648 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -57.1%
2025-11-14
$432,304
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -57.1%
|
2025-11-14 | $432,304 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -55.1%
2025-11-14
$923,652
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.1%
|
2025-11-14 | $923,652 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-14 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.4%
2025-11-13
$348,899
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.4%
|
2025-11-13 | $348,899 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-13 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -83.3%
2025-11-13
$303,801
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -83.3%
|
2025-11-13 | $303,801 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.3%
2025-11-13
$1,664,100Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.3%
|
2025-11-13 | $1,664,100Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.6%
2025-11-13
$599,058
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.6%
|
2025-11-13 | $599,058 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-11-12
$463,235
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-11-12 | $463,235 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-12 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-12
$227,985
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-12 | $227,985 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -14.3%
2025-11-12
$237,921
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -14.3%
|
2025-11-12 | $237,921 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.5%
2025-11-12
$449,536
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.5%
|
2025-11-12 | $449,536 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -37.6%
2025-11-12
$368,915
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -37.6%
|
2025-11-12 | $368,915 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.0%
|
2025-11-12 | $92,404 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-11-11
$494,355
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-11-11 | $494,355 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-11 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -53.9%
2025-11-11
$738,350
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -53.9%
|
2025-11-11 | $738,350 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.7%
2025-11-11
$574,579
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.7%
|
2025-11-11 | $574,579 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-11-10
$224,610
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-11-10 | $224,610 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -84.8%
2025-11-10
$1,568,936Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -84.8%
|
2025-11-10 | $1,568,936Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-10 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -18.6%
2025-11-07
$134,412
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -18.6%
|
2025-11-07 | $134,412 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.0%
2025-11-07
$1,124,988Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.0%
|
2025-11-07 | $1,124,988Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-07 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.1%
2025-11-07
$533,608
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.1%
|
2025-11-07 | $533,608 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -91.2%
2025-11-06
$604,500
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -91.2%
|
2025-11-06 | $604,500 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -64.3%
2025-11-06
$1,189,808Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -64.3%
|
2025-11-06 | $1,189,808Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-06 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.6%
2025-11-05
$434,297
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.6%
|
2025-11-05 | $434,297 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-05
$216,265
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-05 | $216,265 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-05 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -30.7%
2025-11-05
$220,336
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -30.7%
|
2025-11-05 | $220,336 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-11-05
$442,262
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-11-05 | $442,262 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.0%
2025-11-05
$438,762
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.0%
|
2025-11-05 | $438,762 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-04 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.1%
2025-11-04
$216,375
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.1%
|
2025-11-04 | $216,375 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.2%
2025-11-04
$522,079
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.2%
|
2025-11-04 | $522,079 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.4%
2025-11-04
$998,047
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.4%
|
2025-11-04 | $998,047 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.0%
2025-11-03
$438,624
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.0%
|
2025-11-03 | $438,624 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.0%
2025-11-03
$156,359
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.0%
|
2025-11-03 | $156,359 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -27.6%
2025-11-03
$494,506
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -27.6%
|
2025-11-03 | $494,506 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-11-03 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-11-03
$443,010
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-11-03 | $443,010 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -30.7%
2025-11-03
$220,695
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -30.7%
|
2025-11-03 | $220,695 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -17.2%
2025-10-31
$241,561
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -17.2%
|
2025-10-31 | $241,561 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.0%
2025-10-31
$1,112,011Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.0%
|
2025-10-31 | $1,112,011Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-31 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-31
$447,826
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-31 | $447,826 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-10-30
$670,702
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-10-30 | $670,702 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-30
$225,645
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-30 | $225,645 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -69.8%
2025-10-30
$656,891
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -69.8%
|
2025-10-30 | $656,891 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -20.6%
2025-10-30
$242,598
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -20.6%
|
2025-10-30 | $242,598 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-30 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-29 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -87.4%
2025-10-29
$395,991
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -87.4%
|
2025-10-29 | $395,991 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -66.0%
2025-10-29
$870,480
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -66.0%
|
2025-10-29 | $870,480 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.6%
2025-10-29
$476,641
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.6%
|
2025-10-29 | $476,641 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.0%
2025-10-28
$626,872
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.0%
|
2025-10-28 | $626,872 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-28 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.2%
2025-10-28
$823,437
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.2%
|
2025-10-28 | $823,437 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -23.8%
2025-10-28
$211,245
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -23.8%
|
2025-10-28 | $211,245 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -58.0%
2025-10-27
$751,756
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -58.0%
|
2025-10-27 | $751,756 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-27 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-27
$411,954
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-27 | $411,954 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.1%
2025-10-27
$498,462
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.1%
|
2025-10-27 | $498,462 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -71.1%
2025-10-24
$1,243,990Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -71.1%
|
2025-10-24 | $1,243,990Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-24 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-24
$213,200
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-24 | $213,200 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -47.2%
2025-10-24
$239,070
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -47.2%
|
2025-10-24 | $239,070 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-23
$212,080
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-23 | $212,080 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -60.5%
2025-10-23
$1,054,074Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -60.5%
|
2025-10-23 | $1,054,074Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-23 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.4%
2025-10-23
$422,575
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.4%
|
2025-10-23 | $422,575 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -15.3%
2025-10-22
$266,578
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -15.3%
|
2025-10-22 | $266,578 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.9%
2025-10-22
$928,731
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.9%
|
2025-10-22 | $928,731 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -90.0%
2025-10-22
$493,298
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -90.0%
|
2025-10-22 | $493,298 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-22 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-21 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-21
$216,100
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-21 | $216,100 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.4%
2025-10-21
$430,354
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.4%
|
2025-10-21 | $430,354 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -46.4%
2025-10-21
$601,772
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -46.4%
|
2025-10-21 | $601,772 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.3%
2025-10-21
$462,817
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.3%
|
2025-10-21 | $462,817 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2025-10-20 | $84,460 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -79.4%
2025-10-20
$217,110
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -79.4%
|
2025-10-20 | $217,110 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.8%
2025-10-20
$171,022
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.8%
|
2025-10-20 | $171,022 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-20 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -38.7%
2025-10-20
$673,246
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -38.7%
|
2025-10-20 | $673,246 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -55.8%
2025-10-20
$552,512
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -55.8%
|
2025-10-20 | $552,512 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-17 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -89.4%
2025-10-17
$475,537
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -89.4%
|
2025-10-17 | $475,537 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -70.2%
2025-10-17
$1,247,150Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -70.2%
|
2025-10-17 | $1,247,150Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.7%
2025-10-16
$366,200
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.7%
|
2025-10-16 | $366,200 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -36.3%
2025-10-16
$645,338
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -36.3%
|
2025-10-16 | $645,338 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -62.9%
2025-10-16
$713,715
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -62.9%
|
2025-10-16 | $713,715 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-16 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-15
$433,420
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-15 | $433,420 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-15 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.9%
2025-10-15
$434,800
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.9%
|
2025-10-15 | $434,800 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-10-15
$872,944
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-10-15 | $872,944 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -41.0%
2025-10-14
$641,463
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -41.0%
|
2025-10-14 | $641,463 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -12.6%
2025-10-14
$225,890
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -12.6%
|
2025-10-14 | $225,890 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-14 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-10-14
$882,520
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-10-14 | $882,520 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-13 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-10-13
$1,324,200Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-10-13 | $1,324,200Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-13
$437,530
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-13 | $437,530 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-10 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-10-10
$1,335,830Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-10-10 | $1,335,830Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-10
$442,958
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-10 | $442,958 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-09
$445,250
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-09 | $445,250 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-10-09
$451,240
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-10-09 | $451,240 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-09 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.9%
2025-10-09
$899,165
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.9%
|
2025-10-09 | $899,165 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-10-08
$456,520
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-10-08 | $456,520 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-08 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -30.0%
2025-10-08
$552,158
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -30.0%
|
2025-10-08 | $552,158 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -29.8%
2025-10-08
$386,045
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -29.8%
|
2025-10-08 | $386,045 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -44.3%
2025-10-08
$408,726
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -44.3%
|
2025-10-08 | $408,726 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-07
$450,310
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-07 | $450,310 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -88.5%
2025-10-07
$453,280
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -88.5%
|
2025-10-07 | $453,280 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -63.9%
2025-10-07
$903,730
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -63.9%
|
2025-10-07 | $903,730 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-07 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-06
$445,240
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-06 | $445,240 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-10-06
$1,353,525Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-10-06 | $1,353,525Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-06 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-10-03
$443,630
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-10-03 | $443,630 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -91.3%
2025-10-03
$615,315
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -91.3%
|
2025-10-03 | $615,315 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -52.0%
2025-10-03
$725,902
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -52.0%
|
2025-10-03 | $725,902 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-03 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-10-02
$866,125
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-10-02 | $866,125 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-10-02
$873,400
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-10-02 | $873,400 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-02 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-10-01 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -26.1%
2025-10-01
$457,188
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -26.1%
|
2025-10-01 | $457,188 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -68.1%
2025-10-01
$884,408
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -68.1%
|
2025-10-01 | $884,408 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.7%
2025-10-01
$360,200
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.7%
|
2025-10-01 | $360,200 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-30 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.8%
2025-09-30
$1,691,358Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.8%
|
2025-09-30 | $1,691,358Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -10.6%
2025-09-29
$173,518
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -10.6%
|
2025-09-29 | $173,518 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -50.8%
2025-09-29
$756,017
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -50.8%
|
2025-09-29 | $756,017 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -92.5%
2025-09-29
$689,300
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -92.5%
|
2025-09-29 | $689,300 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-29 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 Sell
|
2025-09-29 | $83,692 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-26 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-09-26
$1,286,031Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-09-26 | $1,286,031Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-26
$426,860
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-26 | $426,860 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.8%
2025-09-25
$344,202
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.8%
|
2025-09-25 | $344,202 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -94.7%
2025-09-25
$993,376
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -94.7%
|
2025-09-25 | $993,376 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -21.8%
2025-09-25
$386,161
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -21.8%
|
2025-09-25 | $386,161 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-25 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -84.0%
2025-09-24
$298,115
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -84.0%
|
2025-09-24 | $298,115 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-24 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -80.3%
2025-09-24
$1,438,374Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -80.3%
|
2025-09-24 | $1,438,374Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-09-23
$839,573
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-09-23 | $839,573 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-23 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-23
$833,020
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-23 | $833,020 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-09-22
$835,775
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-09-22 | $835,775 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-22
$833,438
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-22 | $833,438 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-22 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-19 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -96.8%
2025-09-19
$1,644,310Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -96.8%
|
2025-09-19 | $1,644,310Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -48.4%
2025-09-18
$806,535
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -48.4%
|
2025-09-18 | $806,535 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -87.1%
2025-09-18
$356,905
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -87.1%
|
2025-09-18 | $356,905 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -52.6%
2025-09-18
$454,225
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -52.6%
|
2025-09-18 | $454,225 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-18 | $481,040 | M | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-17 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -86.9%
2025-09-17
$346,780
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -86.9%
|
2025-09-17 | $346,780 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -75.9%
2025-09-17
$1,253,907Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -75.9%
|
2025-09-17 | $1,253,907Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-16 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-16
$399,281
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-16 | $399,281 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -95.8%
2025-09-16
$1,201,781Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -95.8%
|
2025-09-16 | $1,201,781Large | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-15 | $481,040 | M | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -91.8%
2025-09-15
$581,356
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -91.8%
|
2025-09-15 | $581,356 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -61.5%
2025-09-15
$1,010,180Large
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -61.5%
|
2025-09-15 | $1,010,180Large | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -31.9%
2025-09-12
$403,910
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -31.9%
|
2025-09-12 | $403,910 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -93.9%
2025-09-12
$809,780
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -93.9%
|
2025-09-12 | $809,780 | S | Form 4 |
|
UTHR
S
UNITED THERAPEUTICS Corp
ROTHBLATT MARTINE A
• CEO
10b5-1 SellΔOwn -24.2%
2025-09-12
$402,210
|
||||||
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
10b5-1 SellΔOwn -24.2%
|
2025-09-12 | $402,210 | S | Form 4 |
| UTHR |
UNITED THERAPEUTICS Corp
|
CEO
Other
|
2025-09-12 | $481,040 | M | Form 4 |